Outcome of advanced, unresectable conventional central chondrosarcoma

Author： Maldegem Annemiek M.   Gelderblom Hans   Palmerini Emanuela   Dijkstra Sander D.   Gambarotti Marco   Ruggieri Pietro   Nout Remi A.   Sande Michiel A. J.   Ferrari Cristina   Ferrari Stefano   Bovée Judith V. M. G.   Picci Piero  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|20|3159-3164

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.20, 2014-10, pp. : 3159-3164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Docetaxel is active in patients with unresectable metastatic or locally advanced pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Thalidomide attenuates weight loss in patients with cachexia secondary to advanced, unresectable, pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Treatment of Advanced Soft Tissue Sarcoma: Conventional Agents and Promising New Drugs

By Wagner Andrew  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 4, 2007-04 ,pp. : 401-410

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Outcome of endoscopic submucosal dissection for early gastric cancer of conventional and expanded indications: Systematic review and meta‐analysis

By  

Journal of Digestive Diseases, Vol. 16, Iss. 2, 2015-02 ,pp. : 67-74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advanced conventional chondrosarcomas: Time to revisit treatments and clinical research for what is not an indolent disease

By Italiano Antoine  

Cancer, Vol. 120, Iss. 20, 2014-10 ,pp. : 3103-3104

Blackwell Publishing

Access to resources Recommend Favorite